scorecard

You Searched For "sii on vaccine trials" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…

Business Insider Latest Story Image
2 mins read

Serum Institute of India threatens to seek ₹100 crore in damages from Chennai volunteer

The SII stated that the medical team informed the volunteer that the complications were unre…

Business Insider Latest Story Image
3 mins read

Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI

SII has also been asked to submit to the DCGI's office details of medication used in accordance wit…

PTI   


Business Insider Latest Story Image
2 mins read

Oxford COVID-19 vaccine human trials to continue in India, says SII

The testing of Covid-19 vaccine being developed by AstraZeneca and University of Oxford has been pu…

Business Insider Latest Story Image
2 mins read

Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market

SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…

Business Insider Latest Story Image
1 min read

Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia

According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…

Business Insider Latest Story Image
1 min read

DGCI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis

"... the new coronavirus variant 'omicron' has already been reported in more than 60 countries and…

PTI   


Business Insider Latest Story Image
1 min read

SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults

Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had last week submitted an …

PTI   


Business Insider Latest Story Image
2 mins read

SII to resume Covid vaccine trials once DCGI gives nod (Ld)

New Delhi, Sep 12 (IANS) Serum Institute of India (SII) said on Saturday it will resume trials in I…

Business Insider Latest Story Image
2 mins read

Covid-19 vaccine trials to continue in India despite halt in UK: SII

New Delhi, Sep 9 (IANS) The clinical trials of Oxford vaccine will continue in India as usual as it…

Business Insider Latest Story Image
1 min read

Chinese hackers target Indian vaccine makers SII and Bharat Biotech: Report

Both SII and Bharat Biotech are involved in producing Covid-19 vaccine. Moreover, Cyfirma add…

Business Insider Latest Story Image
2 mins read

India continues to mull over SII and Bharat Biotech's COVID-19 vaccine candidates

The Subject Expert Committee met on Wednesday to consider the Emergency Use Authorisation (EUA) …

Business Insider Latest Story Image
8 mins read

COVID-19 vaccine updates in India: Oxford’s COVID-19 vaccine trials can be over by December, if SII doesn’t go for emergency licence

Scientists are still looking for a cure for the deadly coronavirus, which has infected millions of …

Business Insider Latest Story Image
2 mins read

COVID-19 vaccine: SII and Bharat Biotech asked to submit more data for emergency approval

The Central Drugs Standard Control Organisation's Subject Expert Committee on Wednesday asked the S…

Business Insider Latest Story Image
1 min read

SII expects nod for Covid-19 vaccine in 'few days'

New Delhi, Dec 28 (IANS) Pune-based Serum Institute of India on Monday expressed hope at the possib…

Business Insider Latest Story Image
2 mins read

No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data

New Delhi, Dec 30 (IANS) The analysis of the additional data and information submitted by Serum Ins…

Business Insider Latest Story Image
2 mins read

SII, Bharat Biotech asked to submit more data for vaccine's emergency approval

New Delhi, Dec 9 (IANS) The Central Drugs Standard Control Organisation's Subject Expert Committee …

Business Insider Latest Story Image
2 mins read

Centre seeks 300-400 mn vaccine doses, says SII's Poonawalla

Pune, Nov 28 (IANS) The Government of India is looking at getting 300-400 million doses of coronavi…

Business Insider Latest Story Image
1 min read

COVID-19 cases in India cross 32 lakh mark, recovery rate rises to 75.92%

With 67,151 fresh coronavirus infections in 24 hours, India's tally mounted to 32,34,474 on Wednesd…

Business Insider Latest Story Image
2 mins read

India requires Rs 80,000 cr for vaccine distribution next year: SII

New Delhi, Dec 19 (IANS) Pune-based vaccine-maker Serum Institute of India, which has partnered wit…